LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: L’expérience des patientes traitées par trastuzumab à domicile.

    Pailler, Christine

    Soins; la revue de reference infirmiere

    2019  Volume 64, Issue 841, Page(s) 38–39

    Abstract: In 2016, the fondation Santé Service made an evaluation of patients' satisfaction when the trastuzumab was injected subcutaneously. Made first at the hospital then at home, this injection way reduce the treatment duration at five minutes. The majority of ...

    Title translation Experience of patients treated at home with trastuzumab.
    Abstract In 2016, the fondation Santé Service made an evaluation of patients' satisfaction when the trastuzumab was injected subcutaneously. Made first at the hospital then at home, this injection way reduce the treatment duration at five minutes. The majority of patients will recommended this way of administration.
    MeSH term(s) Home Care Services ; Humans ; Injections, Subcutaneous ; Patient Satisfaction ; Trastuzumab/administration & dosage
    Chemical Substances Trastuzumab (P188ANX8CK)
    Language French
    Publishing date 2019-12-21
    Publishing country France
    Document type Journal Article
    ZDB-ID 604655-1
    ISSN 0038-0814
    ISSN 0038-0814
    DOI 10.1016/j.soin.2019.10.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: L’administration conjointe de pertuzumab et trastuzumab est faisable en hospitalisation à domicile.

    Pailler, Christine / Gandrille, Nicolas / Poterre, Marc / Cottu, Paul / Delaloge, Suzette

    Bulletin du cancer

    2023  Volume 110, Issue 4, Page(s) 463–466

    Title translation Co-administration of pertuzumab and trastuzumab is practical in home hospitalization.
    MeSH term(s) Humans ; Female ; Trastuzumab ; Antibodies, Monoclonal, Humanized ; Receptor, ErbB-2 ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Breast Neoplasms/drug therapy
    Chemical Substances Trastuzumab (P188ANX8CK) ; pertuzumab (K16AIQ8CTM) ; Antibodies, Monoclonal, Humanized ; Receptor, ErbB-2 (EC 2.7.10.1)
    Language French
    Publishing date 2023-02-15
    Publishing country France
    Document type Letter
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2023.01.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Le rôle de l'infirmière lors d'une chimiothérapie a domicile en HAD.

    Pailler, Christine / Paganucci-Vandenbossche, Frédérique

    Revue de l'infirmiere

    2012  , Issue 184, Page(s) 36–38

    Abstract: The global treatment of cancer patients has become a public health issue. To meet growing nursing needs, home hospitalisation teams provide an important contribution. Experts in administering chemotherapy at home, the nurses of the Santé Service ... ...

    Title translation The role of the nurse in the administering of chemotherapy at home.
    Abstract The global treatment of cancer patients has become a public health issue. To meet growing nursing needs, home hospitalisation teams provide an important contribution. Experts in administering chemotherapy at home, the nurses of the Santé Service association support patients in their wish to remain at home.
    MeSH term(s) Drug Therapy/methods ; Drug Therapy/nursing ; Home Care Services, Hospital-Based/organization & administration ; Home Care Services, Hospital-Based/utilization ; Humans ; Monitoring, Physiologic/methods ; Monitoring, Physiologic/nursing ; Nurse's Role ; Patient Admission ; Professional Practice/organization & administration ; Risk Assessment
    Language French
    Publishing date 2012-10
    Publishing country France
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 632538-5
    ISSN 1293-8505 ; 0397-7900
    ISSN 1293-8505 ; 0397-7900
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Administration de trastuzumab par voie sous-cutanée à domicile : retour d’expérience des patientes traitées en 2016 par l’hospitalisation à domicile Santé Service.

    Pailler, Christine / Chapot, Thierry / Softa, Souad / Gandrille, Nicolas / Ruiz, Deborah / Mathieu, Sylvaine / Delaloge, Suzette

    Bulletin du cancer

    2018  Volume 105, Issue 12, Page(s) 1126–1134

    Abstract: In 2013, the European Medicines Agency authorized a new pharmaceutical formulation of the trastuzumab for breast cancer treatment. The latter allows a sub-cutaneous injection that reduces significantly the injection time and permits an administration at ... ...

    Title translation Subcutaneous administration of trastuzumab at home: Feedback of patients treated in 2016 by Santé service.
    Abstract In 2013, the European Medicines Agency authorized a new pharmaceutical formulation of the trastuzumab for breast cancer treatment. The latter allows a sub-cutaneous injection that reduces significantly the injection time and permits an administration at home. This study aims to assess the experience of patients treated by trastuzumab subcutaneously at home in 2016, and the experience of the nurses who performed these injections. In 2017, a retrospective survey by phone calls could gather the impressions from 84 patients on their treatment. And 60 nurses answered to a written survey. The whole treatment session is estimated to last 30minutes to one hour by most of the patients (60%) and the nurses (85%), with an injection duration below 5 minutes (according to 71% of patients and 77% of nurses). The main side effects described were: rash (reported by 40% of patients and 52% of nurses) and pain (32% of patients and 68% of nurses). Among patients feeling pain, it was estimated as brief and weak by two thirds of them. Eighty-six per cent of patients found the session pleasant. The general impression of the nurses was also satisfying for almost all of them (89%). Overall, the feedback about subcutaneous injections of trastuzumab at home is very positive, for patients as for nurses. This new formulation improves quality and comfort in patients' care.
    MeSH term(s) Administration, Cutaneous ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Breast Neoplasms/drug therapy ; Female ; Home Care Services ; Humans ; Middle Aged ; Nursing Staff ; Pain, Procedural/etiology ; Patient Satisfaction ; Retrospective Studies ; Time Factors ; Trastuzumab/administration & dosage ; Trastuzumab/adverse effects
    Chemical Substances Antineoplastic Agents, Immunological ; Trastuzumab (P188ANX8CK)
    Language French
    Publishing date 2018-11-19
    Publishing country France
    Document type Journal Article
    ZDB-ID 213270-9
    ISSN 1769-6917 ; 0007-4551
    ISSN (online) 1769-6917
    ISSN 0007-4551
    DOI 10.1016/j.bulcan.2018.10.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top